506 related articles for article (PubMed ID: 11699047)
21. Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.
Jucker BM; Schaeffer TR; Haimbach RE; Mayer ME; Ohlstein DH; Smith SA; Cobitz AR; Sarkar SK
Metabolism; 2003 Feb; 52(2):218-25. PubMed ID: 12601636
[TBL] [Abstract][Full Text] [Related]
22. A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles.
Jessen N; Selmer Buhl E; Pold R; Schmitz O; Lund S
Horm Metab Res; 2008 Apr; 40(4):269-75. PubMed ID: 18548386
[TBL] [Abstract][Full Text] [Related]
23. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
24. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
25. [Mechanisms of action of thiazolidinediones].
Girard J
Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
[TBL] [Abstract][Full Text] [Related]
26. Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
Moore GB; Pickavance LC; Briscoe CP; Clapham JC; Buckingham RE; Wilding JP
Diabetes Obes Metab; 2008 Mar; 10(3):251-63. PubMed ID: 18269641
[TBL] [Abstract][Full Text] [Related]
27. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
[TBL] [Abstract][Full Text] [Related]
28. Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle.
Skrobuk P; Kuoppamaa H; Hiukka A; Koistinen HA
Metabolism; 2010 Feb; 59(2):224-30. PubMed ID: 19765783
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.
Kim JK; Fillmore JJ; Gavrilova O; Chao L; Higashimori T; Choi H; Kim HJ; Yu C; Chen Y; Qu X; Haluzik M; Reitman ML; Shulman GI
Diabetes; 2003 Jun; 52(6):1311-8. PubMed ID: 12765938
[TBL] [Abstract][Full Text] [Related]
30. Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue.
Borst SE; Lee Y; Conover CF; Shek EW; Bagby GJ
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E934-8. PubMed ID: 15213061
[TBL] [Abstract][Full Text] [Related]
31. Diadenosine tetraphosphate (Ap4A) induces a diabetogenic situation: its impact on blood glucose, plasma insulin, gluconeogenesis, glucose uptake and GLUT-4 transporters.
Verspohl EJ; Hohmeier N; Lempka M
Pharmazie; 2003 Dec; 58(12):910-5. PubMed ID: 14703972
[TBL] [Abstract][Full Text] [Related]
32. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
33. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
34. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
Cam MC; Brownsey RW; Rodrigues B; McNeill JH
Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidinediones influence plasma steroids of male obese Zucker rats.
Fürnsinn C; Nowotny P; Brunmair B; Gras F; Roden M; Waldhäusl W; Vierhapper H
Endocrinology; 2002 Jan; 143(1):327. PubMed ID: 11751625
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
[TBL] [Abstract][Full Text] [Related]
38. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
Jiang G; Dallas-Yang Q; Li Z; Szalkowski D; Liu F; Shen X; Wu M; Zhou G; Doebber T; Berger J; Moller DE; Zhang BB
Diabetes; 2002 Aug; 51(8):2412-9. PubMed ID: 12145152
[TBL] [Abstract][Full Text] [Related]
40. Effects of exercise training and antioxidant R-ALA on glucose transport in insulin-sensitive rat skeletal muscle.
Saengsirisuwan V; Perez FR; Kinnick TR; Henriksen EJ
J Appl Physiol (1985); 2002 Jan; 92(1):50-8. PubMed ID: 11744642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
